NCT04002037

Differential Efficacy of Corticosteroid Solutions for Non-Operative Treatment of Digit Flexor Tenosynovitis

Differential Efficacy of Corticosteroid Solutions for Non-Operative Treatment of Digit Flexor Tenosynovitis: A Double-Blind Prospective Randomized Clinical Trial
University of Missouri-Columbia·Phase 4·ClinicalTrials.gov·drugRecruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Trigger Finger
Drug/Device/Intervention
Triamcinolone Acetonide 40mg/mL
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
University of Missouri-Columbia
Location
Columbia, United States of America
Timeline & enrollment
Phase
Phase 4
Start date
Jun 25, 2019
End date
Jun 15, 2025
Enrollment
200 participants
Primary outcome

Green classification of trigger finger severity,Green classification of trigger finger severity,Green classification of trigger finger severity,Disabilities of the Arm, Shoulder and Hand (DASH),Disabilities of the Arm, Shoulder and Hand (DASH),Disabilities of the Arm, Shoulder and Hand (DASH),Pain Visual Analog Score (VAS),Pain Visual Analog Score (VAS),Pain Visual Analog Score (VAS),Upper Extremity Scores (PROMIS),Upper Extremity Scores (PROMIS),Upper Extremity Scores (PROMIS)

Summary

Trigger finger is a common cause of hand pain and dysfunction. Its due to chronic
 inflammation of the flexor tendon that leads to a pulley system mismatch. Historically it has
 been managed either conservatively with corticosteroid injections or through a surgical
 release of the A1 pulley. Several corticosteroids have been used for injection-
 dexamethasone, methylprednisolone, triamcinolone, betamethasone, paramethasone, etc. The
 purpose of out study is to determine if a 0.5 cc injection of Triamcinolone 40 mg/mL will be
 the most effective steroid injection for the non-surgical treatment. Approximately 200
 subjects will be enrolled and randomized to one of three treatment arms: Triamcinolone
 40mg/mL, Triamcinolone 10mg/mL and Soluble dexamethasone 4mg/mL. Treatment success will be
 defined as lack of conversion to surgical treatment, or no desire to proceed with surgery
 during study period (3 months).

ICD-10 classifications
Trigger fingerAccessory finger(s)Fused fingersAccessory thumb(s)Clubbing of fingers
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04002037
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT04002037 through Pure Global AI's free database. This Phase 4 trial is sponsored by University of Missouri-Columbia and is currently Recruiting. The study focuses on Trigger Finger. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.